ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 2836 www.adctherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Jan 2nd, 2025 9:05 pm
Is ADC Therapeutics SA (NYSE:ADCT) Worth US$2.0 Based On Its Intrinsic Value? - Jan 2nd, 2025 11:12 am
ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma - Dec 30th, 2024 9:30 pm
ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma - Dec 11th, 2024 12:30 pm
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma - Dec 9th, 2024 12:30 pm
ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial - Dec 6th, 2024 12:30 pm
BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ... - Nov 14th, 2024 7:02 am
ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations - Nov 9th, 2024 2:14 pm
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why - Nov 8th, 2024 6:14 pm
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates - Nov 7th, 2024 1:50 pm
ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update - Nov 7th, 2024 12:30 pm
Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates - Nov 6th, 2024 1:25 pm
ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting - Nov 5th, 2024 2:47 pm
ADC Therapeutics to Present at November Investor Conferences - Nov 4th, 2024 12:15 pm
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - Nov 1st, 2024 1:40 pm
ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024 - Oct 31st, 2024 11:15 am
Institutional investors own a significant stake of 32% in ADC Therapeutics SA (NYSE:ADCT) - Oct 28th, 2024 12:55 pm
ADC Therapeutics to Present at Upcoming Investor Conferences - Sep 3rd, 2024 11:15 am
ADC Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Aug 8th, 2024 12:15 pm
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2024 12:40 pm